Raccomandazioni ad interim di SIBioC per l’analisi sierologica dell’infezione da SARS-CoV-2

Risultato della ricerca: Articlepeer review


The recent pandemic outbreak caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) andassociated with the pathology called COVID-19 (coronavirus disease 2019), has now become one of the most strenuoushealth care challenges since the emergence of the three pandemics caused by influenza viruses during the past century.Throughout the clinical decision-making of COVID-19, laboratory tests are essential for supporting the screening,diagnosis, prognostication and therapeutic monitoring of this severe infectious disease. Serological testing, that reflectsthe humoral immune response developing after interaction between the host and the virus (or its components), enablesto garner a vast array of clinical information which can be especially used in seroprevalence or seroconversion studies.To this end, the Task Force on COVID-19 of the Italian Society of Clinical Biochemistry and Clinical Molecular Biology(SIBioC) has endorsed a series of technical, practical and clinical ad interim recommendations, aimed at facilitating andoptimizing the introduction, clinical usage and governance of SARS-CoV-2 serological immunoassays in routinepractice.
Lingua originaleItalian
pagine (da-a)91-99
Numero di pagine9
RivistaBiochimica Clinica
Stato di pubblicazionePublished - 2021

Cita questo